Welcome to the IBC Network Foundation Canada
The only charitable entity in Canada exclusively dedicated to addressing the challenges posed by Inflammatory Breast Cancer (IBC).
What is inflammatory breast cancer?
Inflammatory Breast Cancer (IBC) is a rare and very aggressive disease where cancer cells invade the dermal (skin) lymphatic channels, causing swelling, redness and an “inflamed” response. About 2.5% of all newly diagnosed breast cancers are IBC. To learn more about IBC, visit our Overview and Symptoms section.
It’s more than a fundraiser—it’s a wake-up call.
THIS ISN’T ABOUT HOW YOU MOVE. IT’S ABOUT WHY.
Inflammatory Breast Cancer is aggressive, underfunded, and often misdiagnosed. It’s not rare—it’s rarely recognized. And in Canada, it has been left out of the conversation for far too long.
We’re changing that.
IBC needs More
Inflammatory Breast Cancer needs more. More education. More research. More support. This isn’t just a slogan—it’s a desperate call for action. We’re fighting a brutal disease that demands everything we’ve got. Your donation can make a real difference. Help us fund the research that can save lives. Help us spread the word so more people know what to look for. Help us provide the support that patients and families in Canada so desperately need.
Join us in this fight.
Every dollar, every share, every effort counts.
Facing IBC: Real Stories
An IBC diagnosis can bring heavy emotions, but it’s important to remember there is still hope. Many online survival statistics are outdated. In the past, IBC had such poor outcomes that survival was often reported in two-year rates rather than the standard five-year rates. Patients were also largely excluded from breast cancer research, limiting treatment advancements. Older studies reported five-year survival around 40% and ten-year survival closer to 30% (Chang et al., 1998). While IBC remains aggressive, progress has been made. With a timely diagnosis and the right treatment, recent studies suggest that stage III patients may now have a five-year survival rate closer to 70%, while newly diagnosed stage IV patients can reach up to 50% (Source: MD Anderson). Outcomes still vary, and more research is needed, but continued advances in care offer new possibilities.
Featured Story
Nathalie’s IBC Story
Meet Nathalie, a Triple Negative Inflammatory Breast Cancer survivor. Her story is a powerful reminder of the importance of trusting your instincts and advocating for yourself when something feels wrong. Despite facing numerous dismissals, Nathalie persisted and fought for the urgent care she knew she needed.
“My name is Nathalie Feldberg and in March 2023 I was diagnosed with IBC triple negative Stage 3. I will be getting my last immunotherapy next week, September 12.
My treatment consisted of 16 weeks of chemo (I only could do 14), a double mastectomy, removal of 45 nodes, 30 radiation treatments, 8 rounds of Xeloda and 17 immunotherapies total.
After my third Covid shot in 2021, I developed a rash on my torso that persisted all of 2022 and until my diagnosis of IBC in March 2023. My breast was itchy and when I scratched it, I felt a lump.
I got a mammogram the next week and was told everything looked good, not to worry. (read more)
Share your story, help raise awareness about Inflammatory Breast Cancer and inspire hope.
Email us info@ibcnetworkcanada.org
Our Mission
To promote and fund Canadian research, educate the public and healthcare professionals, and provide advocacy, information, and support to those affected by IBC.